Xia Zhou

17.9k total citations
131 papers, 2.9k citations indexed

About

Xia Zhou is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Xia Zhou has authored 131 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 15 papers in Immunology and 14 papers in Genetics. Recurrent topics in Xia Zhou's work include Genetic and Kidney Cyst Diseases (12 papers), MicroRNA in disease regulation (10 papers) and Berberine and alkaloids research (7 papers). Xia Zhou is often cited by papers focused on Genetic and Kidney Cyst Diseases (12 papers), MicroRNA in disease regulation (10 papers) and Berberine and alkaloids research (7 papers). Xia Zhou collaborates with scholars based in China, United States and Hong Kong. Xia Zhou's co-authors include Xiaogang Li, Chun‐Sing Lee, H. L. Lai, Lucy X. Fan, Frederick Au, Ning Wang, I. Bello, Ellis D. Avner, William E. Sweeney and Hongying Peng and has published in prestigious journals such as Journal of Clinical Investigation, Applied Physics Letters and PLoS ONE.

In The Last Decade

Xia Zhou

123 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xia Zhou China 31 1.1k 444 403 377 330 131 2.9k
Nana Zhang China 29 852 0.7× 295 0.7× 156 0.4× 175 0.5× 254 0.8× 181 3.5k
Vivek Singh India 33 827 0.7× 278 0.6× 256 0.6× 131 0.3× 837 2.5× 146 4.9k
Takashi Ishikawa Japan 32 1.0k 0.9× 151 0.3× 198 0.5× 287 0.8× 648 2.0× 250 3.8k
Yue Guan China 31 1.5k 1.3× 148 0.3× 396 1.0× 378 1.0× 326 1.0× 123 4.1k
Yutaka Yamamoto Japan 28 1.1k 1.0× 162 0.4× 252 0.6× 193 0.5× 144 0.4× 255 3.2k
Kenji Miyata Japan 32 1.3k 1.1× 370 0.8× 293 0.7× 149 0.4× 736 2.2× 173 3.6k
Yu Sun China 36 1.6k 1.4× 674 1.5× 265 0.7× 242 0.6× 114 0.3× 294 6.3k
Mitsuru Sato Japan 35 1.6k 1.4× 270 0.6× 229 0.6× 185 0.5× 145 0.4× 249 5.0k
Xiaowei Zhang China 40 2.4k 2.1× 593 1.3× 215 0.5× 170 0.5× 413 1.3× 229 5.4k
Yinghui Zhang China 28 1.1k 1.0× 136 0.3× 342 0.8× 213 0.6× 80 0.2× 141 2.5k

Countries citing papers authored by Xia Zhou

Since Specialization
Citations

This map shows the geographic impact of Xia Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Zhou more than expected).

Fields of papers citing papers by Xia Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Zhou. The network helps show where Xia Zhou may publish in the future.

Co-authorship network of co-authors of Xia Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xia Zhou. A scholar is included among the top collaborators of Xia Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xia Zhou. Xia Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhiwei, et al.. (2025). Glymphatic system impairment in cerebral small vessel disease: associations with perivascular space volume and cognition. Frontiers in Aging Neuroscience. 17. 1680094–1680094.
2.
Zhou, Xia, Zhiwei Li, Mingxu Li, et al.. (2024). Disrupted Dynamic Network Attribution Associated with Gait Disorder in Cerebral Small Vessel Disease. Brain Connectivity. 14(6). 327–339.
3.
4.
Zhou, Xia, et al.. (2023). Neoadjuvant immune checkpoint inhibitor therapy and chemotherapy improve pulmonary ventilation and diffusion function in patients with lung cancer. Journal of Zhejiang University (Medical Sciences). 52(5). 588–593.
5.
Xu, Huimin, et al.. (2023). Microbiota alteration of Chinese young male adults with high-status negative cognitive processing bias. Frontiers in Microbiology. 14. 989162–989162. 5 indexed citations
6.
Chen, Zhiqiang, et al.. (2023). Immune functions of C‐type lectins in medical arthropods. Insect Science. 31(3). 652–662. 5 indexed citations
7.
Liao, Yongxiang, Asif Ali, Xia Zhou, et al.. (2022). Disruption of LLM9428/OsCATC Represses Starch Metabolism and Confers Enhanced Blast Resistance in Rice. International Journal of Molecular Sciences. 23(7). 3827–3827. 5 indexed citations
8.
Agborbesong, Ewud, Xia Zhou, Xiaoyan Li, & Xiaogang Li. (2022). SMYD3 Regulates Cyst Growth and Ciliogenesis in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology. 33(11S). 398–398. 1 indexed citations
9.
Wu, Jiahui, Xia Zhou, Qiaoqiao Chen, et al.. (2022). Defensins as a promising class of tick antimicrobial peptides: a scoping review. Infectious Diseases of Poverty. 11(1). 71–71. 21 indexed citations
10.
Lv, Xia, Guangjie Wu, Xia Zhou, et al.. (2021). Glaucoma Is Not Associated With Alzheimer's Disease or Dementia: A Meta-Analysis of Cohort Studies. Frontiers in Medicine. 8. 688551–688551. 19 indexed citations
11.
Yu, Jing, Lei Nie, Dongde Wu, et al.. (2021). Prognostic Value of a Clinical Biochemistry-Based Nomogram for Coronavirus Disease 2019. Frontiers in Medicine. 7. 597791–597791. 5 indexed citations
12.
Deng, Songyun, Shengyao Liu, Shaoyong Xu, et al.. (2020). Shorter Telomere Length in Peripheral Blood Leukocytes Is Associated with Post-Traumatic Chronic Osteomyelitis. Surgical Infections. 21(9). 773–777. 2 indexed citations
13.
14.
Li, Lan, Hourong Zhou, Yu Li, et al.. (2018). Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosis. OncoTargets and Therapy. Volume 11. 7471–7481. 10 indexed citations
15.
Li, Liqun, Qiang Liu, Wenqian Zhang, et al.. (2018). Dihydroartemisinin ameliorates sepsis-induced hyperpermeability of glomerular endothelium via up-regulation of occludin expression. Biomedicine & Pharmacotherapy. 99. 313–318. 27 indexed citations
16.
Zhou, Xia, Xiaonan Chen, Josephine F. Trott, et al.. (2017). Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease. Kidney International. 92(4). 922–933. 10 indexed citations
17.
Zhou, Xia, et al.. (2016). MicroRNA-146a down-regulation correlates with neuroprotection and targets pro-apoptotic genes in cerebral ischemic injury in vitro. Brain Research. 1648(Pt A). 136–143. 30 indexed citations
18.
Chen, Yingyu, Jieru Wang, Beiping Miao, et al.. (2016). Tissue inhibitor of metalloproteinases 1, a novel biomarker of tuberculosis. Molecular Medicine Reports. 15(1). 483–487. 13 indexed citations
19.
Zhou, Xia, Ling Li, Kai He, et al.. (2016). Effects of dietary supplementations with the fibrous root of Rhizoma Coptidis and its main alkaloids on non-specific immunity and disease resistance of common carp. Veterinary Immunology and Immunopathology. 173. 34–38. 18 indexed citations
20.
Chen, Li, Xia Zhou, Lucy X. Fan, et al.. (2015). Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease. Journal of Clinical Investigation. 125(6). 2399–2412. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nana Zhang Breakdown of academic impact, for papers by Vivek Singh Breakdown of academic impact, for papers by Takashi Ishikawa Breakdown of academic impact, for papers by Yue Guan Breakdown of academic impact, for papers by Yutaka Yamamoto Breakdown of academic impact, for papers by Kenji Miyata Breakdown of academic impact, for papers by Yu Sun Breakdown of academic impact, for papers by Mitsuru Sato Breakdown of academic impact, for papers by Xiaowei Zhang Breakdown of academic impact, for papers by Yinghui Zhang
Rankless by CCL
2026